S&P 500   4,577.11 (-1.84%)
DOW   35,368.47 (-1.51%)
QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
S&P 500   4,577.11 (-1.84%)
DOW   35,368.47 (-1.51%)
QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
S&P 500   4,577.11 (-1.84%)
DOW   35,368.47 (-1.51%)
QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
S&P 500   4,577.11 (-1.84%)
DOW   35,368.47 (-1.51%)
QQQ   370.55 (-2.49%)
AAPL   169.80 (-1.89%)
MSFT   302.65 (-2.43%)
FB   318.15 (-4.14%)
GOOGL   2,719.96 (-2.50%)
AMZN   3,178.35 (-1.99%)
TSLA   1,030.51 (-1.82%)
NVDA   259.03 (-3.86%)
BABA   128.60 (-2.26%)
NIO   29.61 (-4.33%)
AMD   131.93 (-3.62%)
CGC   7.78 (-7.38%)
MU   92.87 (-4.61%)
GE   102.89 (-0.26%)
T   27.31 (+0.48%)
F   24.38 (-3.22%)
DIS   152.27 (+0.22%)
AMC   18.84 (-8.41%)
PFE   54.11 (-1.53%)
ACB   5.11 (-7.26%)
BA   225.01 (-0.42%)
NASDAQ:SPRO

Spero Therapeutics Insider Trades

$12.50
-0.70 (-5.30%)
(As of 01/18/2022 12:00 AM ET)
Add
Compare
Today's Range
$11.88
$12.96
50-Day Range
$11.93
$17.26
52-Week Range
$11.69
$22.24
Volume
174,606 shs
Average Volume
148,419 shs
Market Capitalization
$404.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.53

Spero Therapeutics (NASDAQ:SPRO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
13.45%

Number Of
Insiders Buying
(Last 12 Months)
7

Amount Of
Insider Buying
(Last 12 Months)
$7.70 M

Number Of
Insiders Selling
(Last 12 Months)
4

Amount Of
Insider Selling
(Last 12 Months)
$1.00 M

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get SPRO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Spero Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Spero Therapeutics (NASDAQ SPRO) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/10/2022Aquilo Capital Management, LlcMajor ShareholderBuy8,867$12.93$114,650.31  
12/27/2021Ankit MahadeviaCEOSell8,000$14.58$116,640.00  
10/29/2021Aquilo Capital Management, LlcMajor ShareholderBuy150,000$17.53$2,629,500.00  
9/30/2021Aquilo Capital Management, LlcMajor ShareholderBuy134,543$18.65$2,509,226.95  
9/13/2021Aquilo Capital Management, LlcMajor ShareholderBuy44,210$18.56$820,537.60  
9/9/2021Aquilo Capital Management, LlcMajor ShareholderBuy24,749$18.50$457,856.50  
8/30/2021Aquilo Capital Management, LlcMajor ShareholderBuy44,042$17.87$787,030.54  
8/26/2021Aquilo Capital Management, LlcMajor ShareholderBuy22,982$16.55$380,352.10  
2/8/2021Aquilo Capital Management, LlcMajor ShareholderSell3,000$21.74$65,220.00  
2/3/2021Aquilo Capital Management, LlcMajor ShareholderSell29,354$18.98$557,138.92  
2/1/2021Aquilo Capital Management, LlcMajor ShareholderSell13,661$19.24$262,837.64  
12/16/2020Aquilo Capital Management, LlcMajor ShareholderSell14,933$18.62$278,052.46  
12/16/2020Cristina LarkinCOOSell12,000$19.00$228,000.0013,500  
11/9/2020Aquilo Capital Management, LlcMajor ShareholderSell125,900$13.77$1,733,643.00  
11/6/2020Aquilo Capital Management, LlcMajor ShareholderSell174,100$14.09$2,453,069.00  
11/4/2020Aquilo Capital Management, LlcMajor ShareholderSell72,500$14.26$1,033,850.00  
11/3/2020Ankit MahadeviaCEOSell2,137$14.27$30,494.99  
10/23/2020Ankit MahadeviaCEOSell20$14.25$285.00  
10/14/2020Ankit MahadeviaCEOSell105$14.25$1,496.25  
9/8/2020Ankit MahadeviaCEOSell774$14.25$11,029.50  
7/9/2020Ankit MahadeviaCEOSell2,293$14.31$32,812.83  
7/7/2020Ankit MahadeviaCEOSell754$14.25$10,744.50  
7/17/2018Plc GlaxosmithklineMajor ShareholderBuy80,000$12.50$1,000,000.00  
7/6/2018Ankit MahadeviaInsiderSell4,676$17.63$82,437.88  
7/5/2018Cristina LarkinCOOSell4,000$17.50$70,000.00  
7/5/2018Joel SendekCFOSell2,000$17.50$35,000.00  
11/6/2017Casper BreumDirectorBuy214,285$14.00$2,999,990.00  
11/6/2017Cristina LarkinCOOBuy1,500$14.00$21,000.00  
11/6/2017Joel SendekCFOBuy5,000$14.00$70,000.00  
11/6/2017Plc GlaxosmithklineMajor ShareholderBuy428,571$14.00$5,999,994.00  
3/11/2013Allen S GreeneCEOBuy15,000$1.53$22,950.00  
12/28/2012Zohar Ben-DovMajor ShareholderBuy22,693$1.19$27,004.67  
12/24/2012Jack FingerhutPresidentBuy2,000$2.40$4,800.00  
9/5/2012John J GormanDirectorBuy4,600$1.90$8,740.00  
8/30/2012Allen S GreeneCEOBuy5,000$1.82$9,100.00  
(Data available from 1/1/2013 forward)












Spero Therapeutics (NASDAQ:SPRO) Insider Trade Frequently Asked Questions

Who is on Spero Therapeutics's Insider Roster?

The list of insiders at Spero Therapeutics includes Ankit Mahadevia, Aquilo Capital Management, Llc, and Cristina Larkin.Learn more on SPRO's insiders

What percentage of Spero Therapeutics stock is owned by insiders?

13.45% of Spero Therapeutics stock is owned by insiders. Learn more on SPRO's insider holdings

Which Spero Therapeutics insiders have been buying company stock?

The following insider purchased Spero Therapeutics stock in the last 24 months: Aquilo Capital Management, Llc ($7,699,154.00).

How much insider buying is happening at Spero Therapeutics?

Insiders have purchased a total of 429,393 Spero Therapeutics shares in the last 24 months for a total of $7,699,154.00 bought.

Which Spero Therapeutics insiders have been selling company stock?

The following insiders have sold Spero Therapeutics stock in the last 24 months: Ankit Mahadevia ($203,503.07), Aquilo Capital Management, Llc ($6,383,811.02), and Cristina Larkin ($228,000.00).

How much insider selling is happening at Spero Therapeutics?

Insiders have sold a total of 459,531 Spero Therapeutics shares in the last 24 months for a total of $6,815,314.09 sold.

This page was last updated on 1/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.